<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01782859</url>
  </required_header>
  <id_info>
    <org_study_id>2012-008</org_study_id>
    <nct_id>NCT01782859</nct_id>
  </id_info>
  <brief_title>Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip Surgery</brief_title>
  <official_title>Effect of Steroids Given Over 24 Hours on Cytokine Release, Urinary Desmosine Level and Thrombogenic Markers in Patients Undergoing Unilateral Total Hip Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studies have shown that surgery causes some reactions in your body consistent with
      inflammation. When the inflammation is extensive, it may affect different parts of the body
      including the lungs. Corticosteroids are commonly used to treat inflammation and are
      different from performance enhancing steroids associated with athletics. The purpose of this
      study is to determine the influence of low dose steroids given 3 times in a 24 hour period on
      thrombotic markers (markers that are associated with increased risks of clotting, a possible
      complication of surgery), interleukin (IL)-6 cytokine release (part of the stress response
      seen with surgery), and urine desmosine levels (a marker of lung injury) in a randomized
      placebo controlled trial patients undergoing total hip replacement.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum Prothrombin Fragment 1 and 2 (PF 1.2)</measure>
    <time_frame>First 24 hours after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasmin-a 2 Antiplasmin Complex (PAP)</measure>
    <time_frame>First 24 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interleukin (IL)-6 Cytokine Release (Inflammatory Marker)</measure>
    <time_frame>Participants will be followed from the time of surgery until discharge, expected average of 3-5 days</time_frame>
    <description>The time frame of the study for each patient covers the period between time of surgery and until discharge from the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Desmosine Level (Marker of Lung Injury)</measure>
    <time_frame>Participants will be followed from the time of surgery until discharge, expected average of 3-5 days</time_frame>
    <description>The time frame of the study for each patient covers the period between time of surgery and until discharge from the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at 3 Months Post-op</measure>
    <time_frame>3 months postoperatively</time_frame>
    <description>At 3 months postoperatively, patients were asked to rate their pain on a scale of 0-10, with 0 being no pain and 10 being worst pain.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Total Hip Replacement</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prednisone/hydrocortisone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Steroid group will receive the following:
20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prednisone</intervention_name>
    <arm_group_label>Prednisone/hydrocortisone</arm_group_label>
    <other_name>Low dose steroids to be administered preoperatively and then repeated over a 24-hour period</other_name>
    <other_name>1. 20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital</other_name>
    <other_name>2. 100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by</other_name>
    <other_name>3. Another dose of 100 mg hydrocortisone IV 8 hours after</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone</intervention_name>
    <arm_group_label>Prednisone/hydrocortisone</arm_group_label>
    <other_name>Low dose steroids to be administered preoperatively and then repeated over a 24-hour period</other_name>
    <other_name>1. 20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital</other_name>
    <other_name>2. 100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by</other_name>
    <other_name>3. Another dose of 100 mg hydrocortisone IV 8 hours after</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (for Prednisone)</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Lactose filler to mimic 20 mg prednisone tablet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing unilateral total hip replacement with Drs. Douglas Padgett, Thomas
             Sculco, or Edwin Su.

          -  Patients between the age of 50 and 90

        Exclusion Criteria:

          -  Patients on steroid therapy regardless of dose or duration of treatment or those
             requiring stress-dose steroids preoperatively

          -  Patients who are smokers

          -  Patients who have diabetes

          -  Patients who are &lt;50 and &gt;90 years of age

          -  Patients with history of prior difficulties tolerating corticosteroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2013</study_first_submitted>
  <study_first_submitted_qc>January 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2013</study_first_posted>
  <results_first_submitted>April 4, 2016</results_first_submitted>
  <results_first_submitted_qc>April 4, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 10, 2016</results_first_posted>
  <last_update_submitted>November 7, 2016</last_update_submitted>
  <last_update_submitted_qc>November 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Prednisone</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Control group
Placebo (for Prednisone)</description>
        </group>
        <group group_id="P2">
          <title>Prednisone/Hydrocortisone</title>
          <description>Steroid group will receive the following:
20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Control group
Placebo (for Prednisone)</description>
        </group>
        <group group_id="B2">
          <title>Prednisone/Hydrocortisone</title>
          <description>Steroid group will receive the following:
20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="27"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.13" spread="7.16"/>
                    <measurement group_id="B2" value="66.21" spread="8.80"/>
                    <measurement group_id="B3" value="65.66" spread="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/(m^2)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.04" spread="3.92"/>
                    <measurement group_id="B2" value="28.03" spread="4.86"/>
                    <measurement group_id="B3" value="27.00" spread="4.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Serum Prothrombin Fragment 1 and 2 (PF 1.2)</title>
        <time_frame>First 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Control group
Placebo (for Prednisone)</description>
          </group>
          <group group_id="O2">
            <title>Prednisone/Hydrocortisone</title>
            <description>Steroid group will receive the following:
20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Prothrombin Fragment 1 and 2 (PF 1.2)</title>
          <units>pmol/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="334.15" spread="193.9"/>
                    <measurement group_id="O2" value="298.12" spread="124.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wound Closure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="778.33" spread="353.7"/>
                    <measurement group_id="O2" value="619.21" spread="154.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1306.76" spread="445.4"/>
                    <measurement group_id="O2" value="1138.65" spread="435.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1175.71" spread="400.9"/>
                    <measurement group_id="O2" value="1032.52" spread="466.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="356.79" spread="94.9"/>
                    <measurement group_id="O2" value="422.61" spread="191.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plasmin-a 2 Antiplasmin Complex (PAP)</title>
        <time_frame>First 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Control group
Placebo (for Prednisone)</description>
          </group>
          <group group_id="O2">
            <title>Prednisone/Hydrocortisone</title>
            <description>Steroid group will receive the following:
20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV</description>
          </group>
        </group_list>
        <measure>
          <title>Plasmin-a 2 Antiplasmin Complex (PAP)</title>
          <units>mcg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="924.67" spread="324.7"/>
                    <measurement group_id="O2" value="1011.17" spread="212.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wound Closure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1361.23" spread="527.7"/>
                    <measurement group_id="O2" value="2251.33" spread="680.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2251.33" spread="680.1"/>
                    <measurement group_id="O2" value="2455.71" spread="458.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2283.18" spread="711.0"/>
                    <measurement group_id="O2" value="2379.57" spread="395.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="996.39" spread="251.1"/>
                    <measurement group_id="O2" value="914.16" spread="186.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Interleukin (IL)-6 Cytokine Release (Inflammatory Marker)</title>
        <description>The time frame of the study for each patient covers the period between time of surgery and until discharge from the hospital.</description>
        <time_frame>Participants will be followed from the time of surgery until discharge, expected average of 3-5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Control group
Placebo (for Prednisone)</description>
          </group>
          <group group_id="O2">
            <title>Prednisone/Hydrocortisone</title>
            <description>Steroid group will receive the following:
20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV</description>
          </group>
        </group_list>
        <measure>
          <title>Interleukin (IL)-6 Cytokine Release (Inflammatory Marker)</title>
          <description>The time frame of the study for each patient covers the period between time of surgery and until discharge from the hospital.</description>
          <units>picograms/milliliter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.98" spread="2.3"/>
                    <measurement group_id="O2" value="5.69" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wound closure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.46" spread="4.2"/>
                    <measurement group_id="O2" value="4.47" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.21" spread="52.1"/>
                    <measurement group_id="O2" value="56.72" spread="27.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115.17" spread="56.1"/>
                    <measurement group_id="O2" value="64.4" spread="33.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="176.79" spread="91.4"/>
                    <measurement group_id="O2" value="68.51" spread="45.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Desmosine Level (Marker of Lung Injury)</title>
        <description>The time frame of the study for each patient covers the period between time of surgery and until discharge from the hospital.</description>
        <time_frame>Participants will be followed from the time of surgery until discharge, expected average of 3-5 days</time_frame>
        <population>Desmosine levels were not analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Control group
Placebo (for Prednisone)</description>
          </group>
          <group group_id="O2">
            <title>Prednisone/Hydrocortisone</title>
            <description>Steroid group will receive the following:
20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV</description>
          </group>
        </group_list>
        <measure>
          <title>Desmosine Level (Marker of Lung Injury)</title>
          <description>The time frame of the study for each patient covers the period between time of surgery and until discharge from the hospital.</description>
          <population>Desmosine levels were not analyzed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at 3 Months Post-op</title>
        <description>At 3 months postoperatively, patients were asked to rate their pain on a scale of 0-10, with 0 being no pain and 10 being worst pain.</description>
        <time_frame>3 months postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Control group
Placebo (for Prednisone)</description>
          </group>
          <group group_id="O2">
            <title>Prednisone/Hydrocortisone</title>
            <description>Steroid group will receive the following:
20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV
Prednisone
Hydrocortisone</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at 3 Months Post-op</title>
          <description>At 3 months postoperatively, patients were asked to rate their pain on a scale of 0-10, with 0 being no pain and 10 being worst pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.92" spread="0.76"/>
                    <measurement group_id="O2" value="0.54" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Control group
Placebo (for Prednisone)</description>
        </group>
        <group group_id="E2">
          <title>Prednisone/Hydrocortisone</title>
          <description>Steroid group will receive the following:
20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kethy Jules-Elysee, MD</name_or_title>
      <organization>Hospital for Special Surgery</organization>
      <phone>2126061206</phone>
      <email>juleselyseek@hss.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

